Mayer J - Search Results

1

Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR-final report from AFTER-SKI.

Richter J, Lübking A, Söderlund S, Lotfi K, Markevärn B, Själander A, Stenke L, Deneberg S, Ahlstrand E, Myhr-Eriksson K, Panayiotidis P, Gedde-Dahl T, Žáčková D, Mayer J, Olsson-Strömberg U, Mahon FX, Saussele S, Hjorth-Hansen H, Koskenvesa P. Richter J, et al. Among authors: mayer j. Leukemia. 2021 Aug;35(8):2416-2418. doi: 10.1038/s41375-021-01173-w. Epub 2021 Feb 15. Leukemia. 2021. PMID: 33589755 Free PMC article. No abstract available.

2

FGF-2 abnormalities in B cell chronic lymphocytic and chronic myeloid leukemias.

Krejcí P, Dvoráková D, Krahulcová E, Pacherník J, Mayer J, Hampl A, Dvorák P. Krejcí P, et al. Among authors: mayer j. Leukemia. 2001 Feb;15(2):228-37. doi: 10.1038/sj.leu.2402012. Leukemia. 2001. PMID: 11236938

3

Treatment of chronic myeloid leukemia with autologous transplantation using peripheral blood stem cells or bone marrow cultured in IL-2 followed by IL-2, GM-CSF, and IFN-alpha administration.

Hájek R, Zácková D, Büchler T, Penka M, Krahulcová E, Korístek Z, Vinklárková J, Adler J, Janovská E, Indrák K, Faber E, Doubek M, Klabusay M, Oltová A, Kuglík P, Bourková L, Dusek L, Mareschová I, Mayer J, Vorlícek J. Hájek R, et al. Among authors: mayer j. Med Oncol. 2003;20(1):69-76. doi: 10.1385/mo:20:1:69. Med Oncol. 2003. PMID: 12665687 Clinical Trial.

4

Increased expression of fibroblast growth factor receptor 3 in CD34+ BCR-ABL+ cells from patients with chronic myeloid leukemia.

Dvorak P, Dvorakova D, Doubek M, Faitova J, Pacholikova J, Hampl A, Mayer J. Dvorak P, et al. Among authors: mayer j. Leukemia. 2003 Dec;17(12):2418-25. doi: 10.1038/sj.leu.2403152. Leukemia. 2003. PMID: 14562121

5

[Therapy of chronic myeloid leukemia. Uncommon view of the modern approaches].

Mayer J, Zácková D, Klamová H, Doubek M. Mayer J, et al. Cas Lek Cesk. 2008;147(4):206-10. Cas Lek Cesk. 2008. PMID: 18578373 Review. Czech.

6

Successful treatment of steroid-refractory hepatitic variant of liver graft-vs-host disease with pulse cyclophosphamide.

Mayer J, Krejci M, Pospisil Z, Doubek M, Janikova A, Zackova D, Racil Z, Smardova L, Navratil M, Kamelander J. Mayer J, et al. Exp Hematol. 2009 Jun;37(6):767-73. doi: 10.1016/j.exphem.2009.03.006. Exp Hematol. 2009. PMID: 19463776 Free article.

7

Constant BCR-ABL transcript level >or=0.1% (IS) in patients with CML responding to imatinib with complete cytogenetic remission may indicate mutation analysis.

Poláková KM, Polívková V, Rulcová J, Klamová H, Jurcek T, Dvoráková D, Zácková D, Pospísil Z, Mayer J, Moravcová J. Poláková KM, et al. Among authors: mayer j. Exp Hematol. 2010 Jan;38(1):20-6. doi: 10.1016/j.exphem.2009.10.003. Exp Hematol. 2010. PMID: 19837125 Free article.

8

Failure of molecular diagnostics in chronic myeloid leukemia: an aberrant form of e13a2 BCR-ABL transcript causing false-negative results by standard polymerase chain reaction.

Jurcek T, Razga F, Jeziskova I, Dvorakova D, Zackova D, Tomasikova L, Oltova A, Mayer J. Jurcek T, et al. Among authors: mayer j. Leuk Lymphoma. 2010 Mar;51(3):558-61. doi: 10.3109/10428190903572219. Leuk Lymphoma. 2010. PMID: 20148758 No abstract available.

9

Dasatinib in imatinib-resistant or -intolerant CML patients: data from the clinical practice of 6 hematological centers in the Czech Republic.

Klamova H, Faber E, Zackova D, Markova M, Voglova J, Cmunt E, Novakova L, Machova-Polakova K, Moravcova J, Dvorakova D, Michalova K, Brezinova J, Oltova A, Jarosova M, Cetkovsky P, Indrak K, Mayer J. Klamova H, et al. Among authors: mayer j. Neoplasma. 2010;57(4):355-9. Neoplasma. 2010. PMID: 20429627

10

Assessment of adenosine triphosphate-binding cassette subfamily B member 1 (ABCB1) mRNA expression in patients with de novo chronic myelogenous leukemia: the role of different cell types.

Racil Z, Razga F, Polakova KM, Buresova L, Polivkova V, Dvorakova D, Zackova D, Klamova H, Cetkovsky P, Mayer J. Racil Z, et al. Among authors: mayer j. Leuk Lymphoma. 2011 Feb;52(2):331-4. doi: 10.3109/10428194.2010.533220. Epub 2010 Dec 6. Leuk Lymphoma. 2011. PMID: 21133723 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,593 results

Search Page